Adapted Physical Activity Effect on Aerobic Function and in Patients in Pre Liver Transplantation
FAPA
1 other identifier
interventional
30
1 country
2
Brief Summary
Physical exercise has been identified as a major beneficial factor in the management of patients suffering from many chronic diseases especially cancer and in the context of cardiac or pulmonary transplantation. It contributes to an improvement of the quality of life and decreases treatment side effects and mortality. Aerobic fitness is constantly altered in cirrhotic patients and correlated to the severity of the hepatic disease. Moreover, in this setting, other etiological factors may be added like chronic obstructive bronchitis and alcoholic cardiomyopathy. In this population, muscle abnormalities with fatigue and cramps have been described. Muscle weakness in this condition may be comparable to that described in patients with chronic obstructive bronchitis and contributes to the decrease of aerobic fitness. Different causes such as muscle deconditioning, hypoxemia, denutrition, anti-rejection drugs increase this phenomenon after liver transplantation. Finally, the aerobic capacity or VO2max is a prognostic factor for survival and is linked to the number and the length of hospitalizations after liver transplantation (LT). Therefore, physical activity is a valid and relevant way to improve quality of life, increase survival, and limit costs of hospitalizations. The aim of this study is to assess the effects of a personalized physical activity retraining program on aerobic capacity, strength and fatigue, in a population awaiting liver transplantation. Purpose: The hypothesis is that an at home adapted retraining program conducted before LT, and including physical activity (aerobic and strength training), will improve aerobic fitness, peripheral strength, quality of life and decrease the hospitalization length in intensive care unit after LT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2015
CompletedFirst Posted
Study publicly available on registry
October 5, 2015
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedJanuary 7, 2019
September 1, 2018
4.3 years
September 29, 2015
January 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VO2 max at 12 weeks
To evaluate the impact of a personalized physical activity program after 12 weeks of exercise on the aerobic capacity measured by VO2 max, in patients awaiting liver transplantation.
at 12 weeks
Secondary Outcomes (2)
6 minutes walk test at week 12
at 12 weeks
After liver transplantation: aerobic capacity (VO2 max)
3 and 6 months after liver transplantation
Study Arms (2)
A: physical activity program
EXPERIMENTALat home physical activity program (during 12 weeks)
B: conventional management
NO INTERVENTIONconventional management
Interventions
walk (three times per week) and muscle building twice per week with the use of elastic bands. They will include 5 strengthening exercises mobilizing large muscle groups of the lower limbs (abs (if possible for the patient), hamstrings, quadriceps, triceps sural and gluteus maximus).
Eligibility Criteria
You may qualify if:
- Males and females between 18 and 70 years of age,
- Signed informed consent,
- Medical indication to LT whatever the cause of the liver disease
You may not qualify if:
- Inability to understand the instructions of the trial,
- Patients who are subject to a court protection, wardship or guardianship order,
- Uncontrolled cardiac disease and ventricular ejection fraction (vef) \< 50 %,
- Any other serious conditions which are not stabilized and in which physical exercise is contra-indicated,
- Pregnancy or suckling,
- Patients transplanted in extreme emergency.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Limoges Hospital
Limoges, 87 042, France
Tours hospital
Tours, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marilyne DEBETTE-GRATIEN
University Hospital, Limoges
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2015
First Posted
October 5, 2015
Study Start
July 1, 2016
Primary Completion
November 1, 2020
Study Completion
March 1, 2021
Last Updated
January 7, 2019
Record last verified: 2018-09